Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Comp Med ; 52(5): 467-72, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12405642

ABSTRACT

Measles virus (MV), a highly infective paramyxovirus, has caused sporadic epizootics characterized by high morbidity and increased mortality in nonhuman primates. Measles vaccines for human use, although effective, are cost prohibitive for use in primate colonies. We compared the efficacy of one or two doses of Vanguard D-M, a canine distemper-measles (CD-M) vaccine, with a single dose of Attenuvax, a human measles vaccine. Compared with 81% of animals inoculated with Attenuvax, all animals inoculated with one or two doses of Vanguard developed detectable MV antibodies. One year after immunization, six juveniles from each vaccine group, along with three unvaccinated controls, were challenged with pathogenic MV and were monitored for clinical signs of disease, viremia, viral shedding, and immune response. All uninoculated controls developed clinical disease and viremia, and shed virus in nasopharangeal secretions. Subclinical viremia without viral shedding was identified in two Attenuvax- and two single-dose Vanguard-inoculated animals. Viremia was not detected in any two-dose Vanguard-inoculated animals. Significantly higher neutralization antibody titers were observed in animals receiving Vanguard. Results of this study indicate that Vanguard is at least as efficacious as Attenuvax for protection of rhesus macaques. The considerably lower cost of Vanguard makes vaccination against measles in large breeding colonies economically feasible.


Subject(s)
Macaca mulatta/immunology , Measles Vaccine/immunology , Measles/veterinary , Vaccination , Animals , Antibodies, Viral/immunology , Antibody Formation , Distemper/immunology , Distemper Virus, Canine/immunology , Humans , Immunity, Cellular/immunology , Measles/prevention & control , Measles Vaccine/administration & dosage , Measles virus/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology
2.
Vet Anaesth Analg ; 29(3): 117-125, 2002 Jul.
Article in English | MEDLINE | ID: mdl-28404235

ABSTRACT

OBJECTIVE: To document perioperative and anesthetic management of 30 feline renal transplant recipients (1996-1998). STUDY DESIGN: Retrospective clinical study. ANIMALS: Thirty adult cats in end-stage renal failure that underwent heterotopic renal transplantation. MATERIALS AND METHODS: The medical records were reviewed from 30 feline heterotopic renal transplant recipients. Cases were included only if they had been treated for hypertension using a beta-adrenergic antagonist, a calcium channel blocker or hemodialysis. Data regarding signalment, preoperative management, surgical technique, type and doses of anesthetics administered, perioperative hemodynamics and intra- and postoperative complications, postoperative analgesia, morbidity and early mortality were recorded. Data were expressed as mean ± SD. RESULTS: Preanesthetic medication included a combination of an anticholinergic and an opioid (oxymorphone). Anesthesia induction was performed mostly with isoflurane and oxygen delivered by mask. Anesthesia maintenance was primarily achieved with isoflurane in 100% oxygen. Nitrous oxide was often used as part of the anesthetic technique. The mean duration of anesthesia was 4.6 hours ± 27 minutes. The mean renal allograft ischemic time was 60 minutes. During the anesthetic period, the majority of the recipient cats received either fresh whole blood (FWB) (N = 25, 83%), cross-matched packed red blood cells (PRBC) (N = 3, 10%) or fresh frozen plasma (FFP) (N = 2, 7%) combined with a balanced electrolyte solution. Blood products administered averaged 63 ± 34 mL and crystalloid 94 ± 62 mL. The most common treated intraoperative complications were hypotension (N = 14, 47%), hypothermia (N = 13, 43%), metabolic acidosis (N = 11, 37%), hypocalcemia (N = 5, 17%), hypoglycemia (N = 4, 13%), hypertension (N = 2, 7%), bradycardia (N = 1, 3%), and ventricular premature contractions (N = 1, 3%). All cats received opioid analgesics postoperatively. Complications observed in the first 24 hours postoperatively were hypertension (N = 20, 67%), hematuria (N = 14, 47%), electrolyte disturbances (N = 9, 30%), temperature imbalances (N = 5, 17%), decreased PCV requiring blood transfusion (N = 5, 17%), decreased perfusion of a foot associated with external iliac anastomosis technique (N = 5, 17%), seizures associated with hypertension (N = 3, 10%), uroabdomen (N = 2, 7%), acute graft rejection (N = 1, 3%) and, corneal ulceration (N = 1, 3%). Survival rates in the perioperative period were 100, 96.7, and 93.4% intraoperatively, at 24 hours, and 7 days following surgery. CONCLUSION: Successful anesthesia can be performed in critically ill renal transplant recipients. However, for optimal graft function and patient survival, normothermia, normovolemia, normotension, and normal acid-base and electrolyte balance should be carefully maintained. Successful anesthetic management requires understanding of the pathophysiology of end-stage renal disease and the maintenance of homeostasis during the different stages of the perioperative period.

3.
Contemp Top Lab Anim Sci ; 38(4): 12-15, 1999 Jul.
Article in English | MEDLINE | ID: mdl-12086421

ABSTRACT

An aged, overweight, female cynomolgus macaque (Macaca fascicularis) was diagnosed preliminarily with fatal fasting syndrome based on a history of chronic anorexia, weight loss, hepatomegaly, elevated serum alkaline phosphatase, bilirubinuria, and diffuse increased hepatic echogenicity. Histopathologic examination confirmed the diagnosis of severe hepatic lipidosis. A percutaneous endoscopic gastrotomy (PEG) tube was inserted after a month of orogastric tube feedings failed to stimulate normal appetite. Within 2 weeks of twice daily PEG tube feedings, the animal began to eat voluntarily, and PEG tube feedings were discontinued. The PEG tube was removed without incident. Periodic percutaneous ultrasound-guided hepatic biopsies revealed partial resolution of the hepatic lipidosis during the following 18 months. PEG tube placement should be considered as an alternative treatment to provide nutritional support in macaques with fatal fasting syndrome.

SELECTION OF CITATIONS
SEARCH DETAIL
...